A new study reveals that only about 1 in 3 patients with prostate cancer have a successful first CT simulation, while 1 in 6 need to be rescheduled for another day.

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

THERE was a second fund-raising element to the recent Addingham & District Sheep Breeders Association’s charity show and sale ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...

"The odds of me recovering are essentially zero," said Scott Adams, who has prostate cancer that has metastasized to his ...

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

AngioDynamics stock is undervalued, with Med Tech growth in thrombus management and atherectomy. Learn more about the company ...

Giants defensive line coach Andre Patterson has prostate cancer, he revealed Tuesday. Patterson has continued to coach the ...

Nigel Pepper, of Laneshawbridge, donated a Beltex gimmer lamb to be sold in aid of Prostate Cancer UK at a sale day at ...